↓ Skip to main content

Treatment of thyroid tumor : Japanese clinical guidelines

Overview of attention for book
Cover of 'Treatment of thyroid tumor : Japanese clinical guidelines'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction
  3. Altmetric Badge
    Chapter 2 CQ1. What Are the Risk Factors for Thyroid Cancer?
  4. Altmetric Badge
    Chapter 3 CQ2. Is There a Difference in Prognosis Between Adult Thyroid Cancer and Juvenile Thyroid Cancer or Juvenile Follicular Cancer?
  5. Altmetric Badge
    Chapter 4 Column 1. Genetics of Thyroid Cancer
  6. Altmetric Badge
    Chapter 5 Column 2. Prevalence of Various Histological Types of Thyroid Cancer
  7. Altmetric Badge
    Chapter 6 Column 3. Anaplastic Transformation of Differentiated Carcinoma
  8. Altmetric Badge
    Chapter 7 Column 4. Incidence, Morbidity, and Mortality of Thyroid Carcinoma in Japan
  9. Altmetric Badge
    Chapter 8 CQ3. What Is the Frequency (Probability of Cancer Before Examination) of Thyroid Cancer
  10. Altmetric Badge
    Chapter 9 CQ4. What Are the Factors That Increase the Likelihood of Malignancy and What Is the Odds Ratio and Risk Ratio?
  11. Altmetric Badge
    Chapter 10 CQ5. What Are the Physical Signs and Symptoms That Increase the Likelihood of Thyroid Cancer and What Are the Sensitivity and Specificity?
  12. Altmetric Badge
    Chapter 11 CQ6. What Are the Imaging Studies Most Suitable for the Diagnosis of Thyroid Carcinoma and What Are Their Sensitivity, Specificity, and Likelihood Ratio?
  13. Altmetric Badge
    Chapter 12 CQ7. What Are the Blood Chemistry Data That Increase the Likelihood of Thyroid Malignancy and What Are Their Sensitivity, Specificity, and Likelihood Ratio?
  14. Altmetric Badge
    Chapter 13 CQ8. What Are the Sensitivity and Specificity of Aspiration Cytology?
  15. Altmetric Badge
    Chapter 14 CQ9. What Are the Sensitivity and Specificity of Ultrasonography, CT, MRI, Laryngoscopy, and Bronchoscopy in the Preoperative Evaluation of Thyroid Cancer Invasion to the Trachea, Esophagus, and the Recurrent Laryngeal Nerve?
  16. Altmetric Badge
    Chapter 15 CQ10. How Is the Natural History of Nodules Diagnosed as Benign (Growth and Reduction Rates)?
  17. Altmetric Badge
    Chapter 16 CQ11. Does TSH Suppression Therapy Reduce the Size of Tumors Diagnosed as Benign?
  18. Altmetric Badge
    Chapter 17 CQ12. What Is the Intra-Observer Variation in the Pathological Diagnosis of Follicular Carcinoma?
  19. Altmetric Badge
    Chapter 18 CQ13. What Is the Efficacy of Percutaneous Ethanol Injection Therapy for Autonomously Functioning Thyroid Nodules?
  20. Altmetric Badge
    Chapter 19 CQ14. Do Cystic Nodules Decrease in Volume by Aspiration and Drainage of Content Fluid and Percutaneous Ethanol Injection Therapy?
  21. Altmetric Badge
    Chapter 20 CQ15. What Is the Likelihood That Multinodular Goiter Will Be Surgically Resected After Observation?
  22. Altmetric Badge
    Chapter 21 Column 5. Indication for Surgery of Nodular Goiter
  23. Altmetric Badge
    Chapter 22 Column 6. Diagnosis of Anaplastic Carcinoma
  24. Altmetric Badge
    Chapter 23 CQ16. What Is the Most Appropriate and Convenient Risk Classification System for Predicting the Prognosis of Patients with Papillary Carcinoma?
  25. Altmetric Badge
    Chapter 24 CQ17. Does Total (or Near Total) Thyroidectomy Improve the Prognosis of Papillary Carcinoma Patients Compared to Lobectomy or Lobectomy Isthmectomy?
  26. Altmetric Badge
    Chapter 25 CQ18. Does Central Compartment Dissection Improve the Prognosis of Papillary Carcinoma Patients?
  27. Altmetric Badge
    Chapter 26 CQ19. Does Dissection of the Lateral Compartment Improve the Prognosis of Papillary Carcinoma Patients?
  28. Altmetric Badge
    Chapter 27 CQ20. When Can Papillary Microcarcinoma (Papillary Carcinoma Measuring 1 cm or Less) Be Observed Without Immediate Surgery?
  29. Altmetric Badge
    Chapter 28 Column 7. What Is the Acceptable Incidence for Persistent Recurrent Laryngeal Nerve Paralysis and Persistent Hypoparathyroidism as Complications of Thyroid Surgery?
  30. Altmetric Badge
    Chapter 29 Column 8. The Controversy Regarding the Extent of Thyroidectomy for Papillary Carcinoma and Actual Practice in Japan
  31. Altmetric Badge
    Chapter 30 Column 9. Lobectomy and Paratracheal Node Dissection
  32. Altmetric Badge
    Chapter 31 Introduction
  33. Altmetric Badge
    Chapter 32 CQ21. Is It Possible to Diagnose Follicular Carcinoma on Preoperative FNA or Intraoperative Frozen Section Diagnosis?
  34. Altmetric Badge
    Chapter 33 CQ22. Does Classification of Follicular Carcinoma According to the Degree of Invasiveness (Widely Invasive and Minimally Invasive Types) Reflect the Prognosis?
  35. Altmetric Badge
    Chapter 34 CQ23. When Is Completion Total Thyroidectomy Recommended as a Second Surgery for Patients Who Underwent Hemithyroidectomy and Were Diagnosed as Having Follicular Carcinoma on Postoperative Pathological Examination?
  36. Altmetric Badge
    Chapter 35 CQ24. Does Total Thyroidectomy with Radioactive Iodine Ablation and TSH Suppression Therapy Improve Patient Prognosis with Widely Invasive Follicular Carcinoma Compared to Only Limited Thyroidectomy?
  37. Altmetric Badge
    Chapter 36 CQ25. Does Prognosis of Oxyphilic (Hurthle Cell) Follicular Carcinoma Differ from That of Conventional Follicular Carcinoma?
  38. Altmetric Badge
    Chapter 37 CQ26. What Is the Usefulness of RET Gene Mutation Analysis for Medullary Carcinoma?
  39. Altmetric Badge
    Chapter 38 CQ27. What Are the Incidences of Diseases Associated with Hereditary Medullary Carcinoma?
  40. Altmetric Badge
    Chapter 39 CQ28. Do Total Thyroidectomy and Lymph Node Dissection for Sporadic and Hereditary Medullary Carcinoma Improve the Prognosis?
  41. Altmetric Badge
    Chapter 40 CQ29. Is Chemotherapy Effective for Advanced or Relapsed Medullary Carcinoma?
  42. Altmetric Badge
    Chapter 41 CQ30. What Are Prognostic Factors of Medullary Carcinoma?
  43. Altmetric Badge
    Chapter 42 CQ31. What Is the Definition of Poorly Differentiated Carcinoma? What Is Its Prevalence and Prognosis?
  44. Altmetric Badge
    Chapter 43 CQ32. Can Poorly Differentiated Carcinoma Be Diagnosed Preoperatively?
  45. Altmetric Badge
    Chapter 44 CQ33. Do Total Thyroidectomy and Prophylactic Lymph Node Dissection Improve the Prognosis of Patients with Poorly Differentiated Carcinoma?
  46. Altmetric Badge
    Chapter 45 CQ34. Does Additional Surgery Improve the Prognosis of Patients Who Underwent Hemithyroidectomy Under a Diagnosis of Papillary or Follicular Carcinoma, But Who Are Later Diagnosed as Having Poorly Differentiated Carcinoma on Postoperative Pathological Examination?
  47. Altmetric Badge
    Chapter 46 CQ35. Do Therapies Other Than Surgery Improve the Prognosis for Patients with Poorly Differentiated Carcinoma?
  48. Altmetric Badge
    Chapter 47 Column 10. Carcinoma Showing Thymus-Like Differentiation/Intrathyroidal Epithelial Thymoma
  49. Altmetric Badge
    Chapter 48 Introduction
  50. Altmetric Badge
    Chapter 49 CQ36. Does Surgical Treatment for Anaplastic Carcinoma Improve Prognosis?
  51. Altmetric Badge
    Chapter 50 CQ37. Do Adjuvant Therapies Improve the Prognosis of Anaplastic Carcinoma in Patients Who Underwent Curative Surgery?
  52. Altmetric Badge
    Chapter 51 CQ38. Does Combined Modality Therapy for Anaplastic Carcinoma Improve Prognosis?
  53. Altmetric Badge
    Chapter 52 CQ39. Should Relapsed Lesions of Differentiated Carcinoma That Were Diagnosed as Anaplastic Carcinoma Be Treated as Anaplastic Carcinoma?
  54. Altmetric Badge
    Chapter 53 Column 11. When Should Palliative Care Be Considered? Is the Prognosis Explained to Patients?
  55. Altmetric Badge
    Chapter 54 Column 12. Squamous Cell Carcinoma of the Thyroid Is Currently Classified as a Different Histology from Anaplastic Carcinoma. Are Therapeutic Strategies and Prognosis of Squamous Cell Carcinoma Similar to Those of Anaplastic Carcinoma?
  56. Altmetric Badge
    Chapter 55 CQ40. What Are Applications and Roles of Ablation?
  57. Altmetric Badge
    Chapter 56 CQ41. Is Iodine Restriction Necessary Before Ablation?
  58. Altmetric Badge
    Chapter 57 CQ42. What Is the Appropriate Dose of 131 I?
  59. Altmetric Badge
    Chapter 58 CQ43. What Is the Benefit of RAI Therapy for Local Recurrence, Lymph Node Metastasis and Distant Metastasis of Differentiated Thyroid Carcinoma?
  60. Altmetric Badge
    Chapter 59 CQ44. What Is the Application, Effect and Safety of Recombinant Human Thyroid Stimulating Hormone (rhTSH)?
  61. Altmetric Badge
    Chapter 60 Column 13. Comments on RAI Therapy Including the Actual Situation in Japan
  62. Altmetric Badge
    Chapter 61 Column 14. Applications for External Beam Radiotherapy for Differentiated Thyroid Carcinoma
  63. Altmetric Badge
    Chapter 62 Column 15. Is it Appropriate to 131 I Scintigraphy Before RAI Therapy? What Is the Dose?
  64. Altmetric Badge
    Chapter 63 Column 16. What Is the Actual Status of Radiotherapy (External Beam Radiotherapy and 131 I MIBG Therapy)?
  65. Altmetric Badge
    Chapter 64 Column 17. What Are the Side Effects of RAI Therapy and What Is Their Frequency?
  66. Altmetric Badge
    Chapter 65 CQ45. What Is the Indication for Resection of the Recurrent Laryngeal Nerve for Cases Extending There?
  67. Altmetric Badge
    Chapter 66 CQ46. Is Phonetic Function Improved by Reconstruction of the Recurrent Laryngeal Nerve?
  68. Altmetric Badge
    Chapter 67 CQ47. For Cases Extending to the Trachea, Does Sleeve Resection of the Trachea Improve the Survival Rate Compared to Partial Resection (Wedge Resection or Window Resection)?
  69. Altmetric Badge
    Chapter 68 CQ48. Does Tracheal Resection Improve the Survival Rate Compared with No Resection?
  70. Altmetric Badge
    Chapter 69 Column 18. Treatment and Management Approaches for Cases Extending to the Trachea with Larynx, Esophagus, or Mediastinum Involvement
  71. Altmetric Badge
    Chapter 70 CQ49. Does TSH Suppression Therapy After Surgery for Differentiated Thyroid Carcinoma Improve Survival?
  72. Altmetric Badge
    Chapter 71 CQ50. Is Serum Thyroglobulin Measurement Useful as a Marker of Carcinoma Recurrence After Surgery?
  73. Altmetric Badge
    Chapter 72 CQ51. Are Measurements of Calcitonin and CEA Useful as Markers of Recurrence After Surgery for Medullary Carcinoma?
  74. Altmetric Badge
    Chapter 73 CQ52. What Are Useful Imaging Studies to Detect Lesions of Recurrence for Medullary Carcinoma with Elevation of Postoperative Calcitonin Level?
  75. Altmetric Badge
    Chapter 74 CQ53. Is Chemotherapy for Advanced Thyroid Carcinoma Effective?
  76. Altmetric Badge
    Chapter 75 CQ54. Is Percutaneous Ethanol Injection Therapy Effective for Local or Lymph Node Recurrence and Bone Metastasis?
  77. Altmetric Badge
    Chapter 76 CQ55. Are Alternate Therapies Effective for Thyroid Carcinoma?
  78. Altmetric Badge
    Chapter 77 Column 19. How Long Should Patients with Differentiated Thyroid Carcinoma Be Followed After Surgery?
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of thyroid tumor : Japanese clinical guidelines
Published by
Springer Science & Business Media, July 2012
DOI 10.1007/978-4-431-54049-6
ISBNs
978-4-43-154048-9, 978-4-43-154049-6, 978-4-43-154721-1
Authors

Takami, Hiroshi, Ito, Yasuhiro

Editors

Takami, Hiroshi, Ito, Yasuhiro, Noguchi, Hitoshi, Yoshida, Akira, Okamoto, Takahiro

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 33%
Other 1 33%
Unknown 1 33%
Readers by discipline Count As %
Medicine and Dentistry 2 67%
Unknown 1 33%